TY  - GEN
AU  - Jiang,Chunling
AU  - Wang,Huan
AU  - Xia,Chaofei
AU  - Dong,Qing
AU  - Chen,En
AU  - Qiu,Yang
AU  - Su,Yong
AU  - Xie,Honghui
AU  - Zeng,Lei
AU  - Kuang,Jie
AU  - Ao,Fan
AU  - Gong,Xiaochang
AU  - Li,Jingao
AU  - Chen,Tingtao
TI  - A randomized, double-blind, placebo-controlled trial of probiotics to reduce the severity of oral mucositis induced by chemoradiotherapy for patients with nasopharyngeal carcinoma
SN  - 1097-0142
PY  - 2019///1230
KW  - Adult
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Bifidobacterium longum
KW  - Chemoradiotherapy
KW  - Cisplatin
KW  - DNA, Bacterial
KW  - analysis
KW  - Double-Blind Method
KW  - Enterococcus faecium
KW  - Female
KW  - Gastrointestinal Microbiome
KW  - genetics
KW  - High-Throughput Nucleotide Sequencing
KW  - Humans
KW  - Lactobacillus
KW  - Male
KW  - Middle Aged
KW  - Nasopharyngeal Carcinoma
KW  - therapy
KW  - Nasopharyngeal Neoplasms
KW  - Probiotics
KW  - therapeutic use
KW  - Radiotherapy, Intensity-Modulated
KW  - Sequence Analysis, DNA
KW  - Severity of Illness Index
KW  - Stomatitis
KW  - prevention & control
N1  - Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/cncr.31907
ER  -